← Leaderboards
George Kenneth Lewis
Zetroz, Inc.
$15,879,261
Attributed
$15,879,261
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.8M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,879,261 · 6
By mechanism
R44$14,583,396 · 3
R43$1,295,865 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDegenerative PolyarthritisPainHourDevicesCommercializationPlacebosCouplingInnovationPain ManagementUnited StatesTechnologyDesignAffectKnee OsteoarthritisTissuesCardiovascular SystemNon-Steroidal Anti-Inflammatory AgentsParticipantArthritisExerciseMedicalQuality Of LifeGastrointestinal
Grant awards (18)
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$2,359,304
R44 · FY2025 · AG · contact PI
Clinical Optimization of Ultrasonic Drug Delivery Technologies for US Veteran Populations that Experience Health Disparities with Arthritis and Chronic Pain$1,457,643
R44 · FY2025 · MD · contact PI
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$2,196,474
R44 · FY2024 · AG · contact PI
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,578,495
R44 · FY2024 · MD · contact PI
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$1,482,405
R44 · FY2023 · MD · contact PI
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,438,616
R44 · FY2022 · AG · contact PI
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,427,916
R44 · FY2021 · AG · contact PI
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$233,597
R43 · FY2021 · MD · contact PI
Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis$1,442,543
R44 · FY2020 · AG · contact PI
Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain$217,772
R43 · FY2020 · MD · contact PI
Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis$223,719
R43 · FY2019 · AG · contact PI
Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis$224,176
R43 · FY2018 · AG · contact PI
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$400,000
R44 · FY2017 · MD · contact PI
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$400,000
R44 · FY2016 · MD · contact PI
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$268,958
R44 · FY2015 · MD · contact PI
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations$131,042
R44 · FY2015 · MD · contact PI
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Rural C$200,000
R43 · FY2014 · MD · contact PI
Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Rural C$196,601
R43 · FY2013 · MD · contact PI